EAF2 mediates germinal centre B-cell apoptosis to suppress excessive immune responses and prevent autoimmunity

Nature Communications

Volumn 7, Issue , 2016, Pages

  Li, Yingqian ^a,b,c   Takahashi, Yoshimasa ^d   Fujii, Shin Ichiro ^e   Zhou, Yang ^a   Hong, Rongjian ^a   Suzuki, Akari ^e   Tsubata, Takeshi ^f   Hase, Koji ^b,c   Wang, Ji Yang ^a,f  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF TOKYO   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e RIKEN Center for Integrative Medical Sciences   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COLLAGEN TYPE 2; DOUBLE STRANDED DNA ANTIBODY; ELL ASSOCIATED FACTOR 2; PROTEIN; RHEUMATOID FACTOR ANTIBODY; UNCLASSIFIED DRUG; FESTA PROTEIN, MOUSE; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ANTIBODY; APOPTOSIS; CELLS AND CELL COMPONENTS; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; APOPTOSIS; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; EMBRYO; FEMALE; GERMINAL CENTER; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MEMORY CELL; MOUSE; NONHUMAN; SPLEEN CELL; UPREGULATION; ANIMAL; B LYMPHOCYTE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PEYER PATCH; PHYSIOLOGY; SPLEEN;

MUS;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; B-LYMPHOCYTES; GENE EXPRESSION REGULATION; MICE; NUCLEAR PROTEINS; PEYER'S PATCHES; SPLEEN; TRANS-ACTIVATORS;

EID: 84960154083     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10836     Document Type: Article

References (52)

1. Peperzak, V., Vikstrom, I. B. & Tarlinton, D. M. Through a glass less darkly: apoptosis and the germinal center response to antigen. Immunol. Rev. 247, 93-106 (2012).
2. Pulendran, B., Kannourakis, G., Nouri, S., Smith, K. G. & Nossal, G. J. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375, 331-334 (1995).
3. Shokat, K. M. & Goodnow, C. C. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375, 334-338 (1995).
4. Han, S., Zheng, B., Dal Porto, J. & Kelsoe, G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl IV. affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J. Exp. Med. 182, 1635-1644 (1995).
5. Chan, T. D. et al. Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen. Immunity 37, 893-904 (2012).
6. Shlomchik, M. J., Marshak-Rothstei, A., Wolfowicz, C. B., Rothstein, T. & Weigert, M. G. The role of clonal selection and somatic mutation in autoimmunity. Nature 328, 805-811 (1987).
7. Radic, M. Z. & Weigret, M. Genetic and structural evidence for antigen selection of anti-DNAantibodies. Annu. Rev. Immunol. 12, 487-520 (1994).
8. Ray, S. K., Putterman, C. & Diamond, B. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc. Natl Acad. Sci. USA 93, 2019-2024 (1996).
9. Danial, N. N. & Korsmeyer, S. J. Cell death: critical control points. Cell 116, 205-219 (2004).
10. Strasser, A. et al. The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control. Ann. N Y Acad. Sci. 917, 541-548 (2000).
11. Smith, K. G., Weiss, U., Rajewsky, K., Nossal, G. J. & Tarlinton, D. M. Bcl-2 increases memory B cell recruitment but does not perturb selection in germinal centers. Immunity 1, 803-813 (1994).
12. Smith, K. G. et al. bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells. J. Exp. Med. 191, 475-484 (2000).
13. Takahashi, Y. et al. Relaxed negative selection in germinal centers and impaired affinity maturation in bcl-xL transgenic mice. J. Exp. Med. 190, 399-410 (1999).
14. Vikstrom, I. et al. Mcl-1 is essential for germinal center formation and B cell memory. Science 330, 1095-1099 (2010).
15. Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H. & Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147 (1995).
16. Takahashi, Y., Ohta, H. & Takemori, T. Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 14, 181-192 (2001).
17. Hao, Z. et al. Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 29, 615-627 (2008).
18. Simone, F. et al. EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein. Blood 98, 201-209 (2001).
19. Simone, F., Luo, R. T., Polak, P. E., Kaberlein, J. J. & Thirman, M. J. ELLassociated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood 101, 2355-2362 (2003).
20. Wang, Z., Tufts, R., Haleem, R. & Cai, X. Genes regulated by androgen in the rat ventral prostate. Proc. Natl Acad. Sci. USA 94, 12999-13004 (1997).
21. Xiao, W. et al. Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer. Cancer Res. 63, 4698-4704 (2003).
22. Kong, S. E., Banks, C. A., Shilatifard, A., Conaway, J. W. & Conaway, R. C. ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL. Proc. Natl Acad. Sci. USA 102, 10094-10098 (2005).
23. Qiao, Z., Wang, D., Hahn, J., Ai, J. & Wang, Z. Pirin down-regulates the EAF2/ U19 protein and alleviates its growth inhibition in prostate cancer cells. Prostate 74, 113-120 (2014).
24. Pascal, L. E. et al. Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice. PLoS ONE 8, e79542 (2013).
25. Rose, M. L., Birbeck, M. S., Wallis, V. J., Forrester, J. A. & Davies, A. J. Peanut lectin binding properties of germinal centres of mouse lymphoid tissue. Nature 284, 364-366 (1980).
26. MacLennan, I. C. Germinal centers. Annu. Rev. Immunol. 12, 117-139 (1994).
27. Lentz, V. M. & Manser, T. Cutting edge: germinal centers can be induced in the absence of T cells. J. Immunol. 167, 15-20 (2001).
28. Frey, S. et al. Mismatch repair deficiency interferes with the accumulation of mutations in chronically stimulated B cells and not with the hypermutation process. Immunity 9, 127-134 (1998).
29. Jolly, C. J., Klix, N. & Neuberger, M. S. Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res. 25, 1913-1919 (1997).
30. Masuda, K. et al. DNA polymerase Z is a limiting factor for A:T mutations in Ig genes and contributes to antibody affinity maturation. Eur. J. Immunol. 38, 2796-2805 (2008).
31. Brink, R. The imperfect control of self-reactive germinal center B cells. Curr. Opin. Immunol. 28, 97-101 (2014).
32. Brand, D. D., Latham, K. A. & Rosloniec, E. F. Collagen-induced arthritis. Nat. Protoc. 1, 1269-1275 (2007).
33. Gitlin, A. D., Shulman, Z. & Nussenzweig, M. C. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 509, 637-640 (2014).
34. Oropallo, M. A. & Cerutti, A. Germinal center reaction: antigen affinity and presentation explain it all. Trends Immunol. 35, 287-289 (2014).
35. Fischer, S. F. et al. Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells. Blood 110, 3978-3984 (2007).
36. Schroeder, K., Herrmann, M. & Winkler, T. H. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity 46, 121-127 (2013).
37. Detanico, T. et al. Somatic mutagenesis in autoimmunity. Autoimmunity 46, 102-114 (2013).
38. Smith, K. G., Nossal, G. J. & Tarlinton, D. M. FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc. Natl Acad. Sci. USA 92, 11628-11632 (1995).
39. Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59 (2008).
40. Strasser, A. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5, 189-200 (2005).
41. Wensveen, F. M. et al. BH3-only protein Noxa regulates apoptosis in activated B cells and controls high-affinity antibody formation. Blood 119, 1440-1449 (2012).
42. Clybouw, C. et al. Regulation of memory B-cell survival by the BH3-only protein Puma. Blood 118, 4120-4128 (2011).
43. Strasser, A., Whittingham, S. & Vaux, D. L. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl Acad. Sci. USA 88, 8661-8665 (1991).
44. Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738 (1999).
45. Xiao, W. et al. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia. Oncogene 27, 1536-1544 (2008).
46. Wu, C. et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130 (2009).
47. Webb, R. et al. Variants within MECP2, a key transcriptional regulator, are associated with increased susceptibility to lupus and differential gene expression in lupus patients. Arthritis Rheum. 60, 1076-1084 (2009).
48. Ouchida, R., Kurosaki, T. & Wang, J. Y. A role for lysosomal-associated protein transmembrane 5 in the negative regulation of surface B cell receptor levels and B cell activation. J. Immunol. 185, 294-301 (2010).
49. Wang, J., Koizumi, T. & Watanabe, T. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice. J. Exp. Med. 184, 831-838 (1996).
50. Jacob, J., Kassir, R. & Kelsoe, G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell population. J. Exp. Med. 173, 1165-1175 (1991).
51. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501 (1992).
52. Rosloniec, E. F., Cremer, M., Kang, A. H., Myers, L. K. & Brand, D. D. Current Protocols in Immunology Chapter 15 unit 15.5, pp 1-25 (2010).